Beyond Meat priced its initial public offering at $25 and skyrocket 800% in less than four months. Beyond Meat, a maker of plant-based meat controls about 10% of the plant based meat market.  And because they have achieved “first to market” they are the new IT THING on Wall Street.  But there valuation is beyond ridiculous.   Their valuation is higher than roughly 25% of the companies in the S&P 500 index and their “first to market” competitive advantage expired.

Kellogg (K) introduced “Incogmeato” and their plant-based burger patties, Chik’n tenders, and Chik’n nuggets which go on sale in early 2020.  Hormel Foods announced its plant-based meat substitute called “Happy Little Plants” is available at select retailers.  The Impossible Foods launched the Impossible Burger through Burger King in August.  Kroger said they will sell a new line of branded plant-based burgers, other meatless products like dips, pasta sauces and cookie dough in the coming months under their Simple Truth Plant Based label.

Beyond Meat Inc. was initiated at sell with a $120 price target at CFRA, with analyst Arun Sundaram saying the plant-based meat company will be overtaken by bigger players entering the space.

“We think larger packaged food companies will end up as the category leaders in the space given their vast global footprint and embedded relationships throughout the supply chain,” Sundaram wrote in a note. “Yet we expect Beyond Meat to be the greatest disrupter in this space since no public packaged food peer comes close to Beyond Meat in terms of research and development spend as a percentage of sales.”

Sundaram notes that “many think Impossible Foods’ Impossible Burger tastes better than the Beyond Burger.”

Source

The call is a bit late and should have been made when the chart was suggesting that price was going lower.

But now we are just $10 from that $100 level I talked about one month ago.

The $100 level represents price at a discount.  But, don’t listen to me, just pay attention to what the Smart Money is doing.

Heading into the third quarter of 2019, a total of 16 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 16 from one quarter earlier.

With a general bullishness amongst the heavyweights, some big names have jumped into Beyond Meat, Inc. (NASDAQ:BYND) headfirst. Citadel Investment Group, managed by Ken Griffin, created the most valuable call position in Beyond Meat, Inc. (NASDAQ:BYND). Citadel Investment Group had $117.8 million invested in the company at the end of the quarter. OZ Management also initiated a $11.9 million position during the quarter. The other funds with brand new BYND positions are Brad Farber’s Atika Capital, Robert Henry Lynch’s Aristeia Capital, and Anthony Bozza’s Lakewood Capital Management.

Source

I personally envision the $100 level will be an accumulation level for the Smart Money.  I think price will hang out near the $100 level for a bit, until the Smart Money is able to fill all their buy orders and then I think price will move higher.

Prediction…Beyond Meat Goes Down To $100 First Before Up To $200

Prediction…Beyond Meat Goes Down To $100 First Before Up To $200 – Part 2

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon’s natural hand movements outside the body into corresponding micro-movements inside the patient’s body.

Intuitive Surgical, Inc. has been at the forefront of robot-assisted surgery for more than two decades. The beauty of their products is they allow quicker recovery times for patients undergoing surgery through minimally-invasive surgery which lower the bill for all parties involved.

Traditional open surgery involves a large cut so the surgeon can see the part of the bodying being worked on.  Minimally invasive surgery involves small cuts and accessories like small tools, cameras, and lights that fit through several tiny cuts in your skin.  And minimally invasive surgeries done by robotic technology allows for more precise control through an operative field in 3-D resulting in a speedier recovery spent at home vs. in the hospital. 

Robotic surgery is steadily carving its niche across a wide array of surgical fields within MedTech. In neurosurgery, image-guided robots enable the examination of brain lesions without resulting in any major damage to adjacent tissues.   In orthopedics, robotic surgery helps shape the femur to precisely fit prosthetic hip-joint replacements. Currently, an increasing number of orthopedic surgeons are opting for robot-assisted surgery for knee, hip and spine.  Robot-assisted surgery has also been finding its application in urology, especially in prostatectomy. Complex gynecological surgeries have also been witnessing the increasing adoption of robotics, using the Da Vinci Surgical System.

Source

It’s no wonder that over
the last five years, Intuitive Surgical earnings per share have grown 21% per
year, which has translated for their stock price increasing 28% per year during
that same time frame.  And this past
week, their earning results continue to impress.

Intuitive Surgical
reported earnings per share of $3.43 a share in the third quarter, beating
expectations of $2.96.  Revenue also
topped expectations at $1,128 million, compared to $921 million in the third
quarter of 2018.

The company credited the earnings beat due to increased U.S. general surgery and worldwide urologic procedures utilizing their da Vinci robot.

275 da Vinci robot were shipped in the quarter, an increase of 19% vs. the year-earlier period.  There are now there were 5,406 installed da Vinci systems worldwide and this number will only increase as the cost of health care continues to rise.

Source

Speaking of rising, where is the stock heading next, let go to the charts to find out? Right now the playing field is between the weekly demand at $450 and the weekly supply at $580.

Thus, the chart suggests to go short if price makes it up to the daily supply at $580.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

WD-40 which stands for “water displacing” was first used by the military in the ’50s to clean up Atlas missile parts. Throughout the years, people have found over 2000 uses for WD-40. Growing up in the projects of NYC, I have seen my fair share of roaches, but I just found out I in addition to using Raid Roach spray, I could of used WD-40 for instant kills as well.

Three months ago, I wrote a post about WD-40,

Did You Go Out And Buy WD-40 Too???

We all know it, have seen it, probably even take it for granted. I’m talking about WD-40. It has infinite uses and is the real utility knife. Just to get you acquainted again with WD-40, here are just 10 of the the 2000 uses of WD-40.

Despite the bump up in price this week, the levels in play and to monitor are the $150 level on the downside and the $188 level on the upside.

I like to think I’m creative with my titles, so the title three months ago was a play on words. Everyone should have WD-40 in the cabinet. However, WD-40 wasn’t a buy three months ago simply put, because the upper limit was $190, the reward wasn’t worth the risk. But thinking about this further, I guess it’s all relative and depends on what type of investor / trader you are. Anyway lets get back to WD-40.

WD-40 is a straight cash money making machine.  The company has grown their dividends on a year basis that’s equivalent to 9% over the last 10 years.  WD-40 has been growing its earnings per share at 13% each year over the past 5 years.  It’s no wonder institutional investors hold almost 90% of the stock. 

WD-40 reported earnings this past week. Although they beat earnings expectations, their outlook was below expectations and on the news the stock price fell the next trading day, but came storming back closing $7 up on the day. However, the fact that price breached a major resistance/support line, I think the risk is to the downside now.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.

The U.S.-China trade war will cut 2019 global growth to its slowest pace since the 2008-2009 financial crisis, the International Monetary Fund warned on Tuesday, adding that the outlook could darken considerably if trade tensions remain unresolved.

Earlier this week, the International Monetary Fund (IMF) said its latest projections for the world economy show 2019 GDP growth at 3.0%, down from 3.2% in a July forecast.  The main culprit was the US-China trade war which is expected to cut 2019 global growth to its slowest pace since the Great Recession. 

Although, the US and China reached a phase I trade deal last week, the IMF stated if deal isn’t reached in the near future, the slowdown in the world economy could worsen, case in point….China.

China’s growth outlook for the remainder of the year and into 2020 is expected to weaken further because of obstacles including drag from the ongoing trade war with the United States, analysts said.

The next mile marker in China’s economic slowdown will come on Friday, when the country reports third quarter growth. Analysts expect it to slow to 6.1 per cent from the 6.2 per cent rate seen in the second quarter, which was the lowest growth rate since the government started publishing quarterly gross domestic product (GDP) statistics in the first quarter of 1992.

But analysts are rapidly revising down their expectations for 2020 below the lower end of this year’s growth range. Most forecasts put next year’s growth between 5.5 per cent and 5.9 per cent, with the International Monetary Fund’s just-released projection at 5.8 per cent.

Source

The MSCI Emerging Markets Index stands for Morgan Stanley Capital International (MSCI) and is an index used to measure equity market performance in global emerging markets.   The MSCI ETF that tracks this index is heavily exposed to China.  So where is price of the MSCI ETF headed, lets go to the charts?

Monthly Chart (Curve Time Frame) – monthly demand is at $120.

Weekly Chart (Trend Time Frame) – the trend is still up, but momentum appears to be stalling.

Daily Chart (Entry Time Frame) – the chart suggests once the support breaks, to look for shorts to the down side with a first target at the weekly demand at $172.

This post is my personal opinion. I’m not a financial advisor, this isn’t financial advise. Do your own research before making investment decisions.